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Abstract
Severe mental illness is characterised by a 20-year mortality gap due to cardiometabolic disease. Poor diet in those with severe mental illness is
an important and modifiable risk factor. The present study aimed to (i) examine baseline nutritional intake in youth with first-episode
psychosis (FEP), (ii) evaluate the feasibility and acceptability of nutritional intervention early in FEP and (iii) to evaluate the effectiveness of
early dietary intervention on key nutritional end points. Participants were recruited over a 12-month period from a community-based
programme specifically targeting young people aged 15–25 years with newly diagnosed FEP. Individual dietetic consultations and practical
group sessions were offered as part of a broader lifestyle programme. Dietary assessments were conducted before and at the end of the
12-week intervention. Participants exceeded recommended energy and Na intakes at baseline. Retention within the nutrition intervention was
67%, consistent with other interventions offered to FEP clients. There was a 47% reduction in discretionary food intake (−94 g/d, P< 0·001)
and reductions in daily energy (−24%, P< 0·001) and Na (−26%, P< 0·001) intakes. Diet quality significantly improved, and the mean change
was 3·6 (95% CI 0·2, 6·9, P< 0·05), although this finding was not significant after Bonferroni’s correction. Increased vegetable intake was the
main factor contributing to improved diet quality. Nutrition intervention delivered shortly after initiation of antipsychotic medication is feasible,
acceptable and effective in youth with FEP. Strategies to prevent weight gain and metabolic decline will contribute to prevent premature
cardiometabolic disease in this vulnerable population.
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People with severe mental illness (SMI) such as schizophrenia,
schizoaffective disorder, bipolar affective disorder and depres-
sion with psychotic features have a reduction in life expectancy
of up to 20 years, which has been labelled a ‘scandal of pre-
mature mortality’(1). Further, recent evidence shows that the
mortality gap is widening(2). Standard treatment for psychotic
illness includes long-term antipsychotic medications (APM)
combined with psychosocial interventions delivered by a mul-
tidisciplinary team(3,4).
APM can induce rapid weight gain with associated metabolic
abnormalities(5,6). This rapid weight gain is most significant
during the first 12 weeks after APM initiation, with a mean
increase of 8 kg during this period, progressing to 12 kg over the
first 2 years and 18 kg over the first 4 years of treatment(5). This
weight gain contributes to the high rates of overweight and
obesity in people with established SMI, with twice the rate of
diabetes and rates of hypercholesterolaemia up to five times
that of the general population(7–9). Weight gain and cardiome-
tabolic risk evolution associated with APM has been reviewed
elsewhere(10). In addition to APM, factors contributing to weight
gain include energy-dense, highly processed, high-salt diets(11)
and lower levels of physical activity(12) compared with the
general population, as well as higher rates of smoking and
substance use(13,14).
Abbreviations: APM, antipsychotic medication; EPP, Early Psychosis Program; FEP, first-episode psychosis; KBIM, Keeping the Body in Mind; SMI, severe
mental illness.
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A high proportion of people receiving APM report con-
siderably increased hunger and excessive night hunger, a
decreased feeling of satiety and increased cravings for sweet
foods and drinks(15,16). Additional eating behaviours in this
population include high levels of fast food consumption, low
food literacy, fast-eating syndrome and habits such as only
eating one main meal daily(16).
Studies that have examined dietary intake of people with SMI
have focused on people with chronic SMI, and are summarised in
a systematic review that reported higher intakes of SFA and Na
and lower intakes of fruit and fibre(11). Studies of energy intake
found higher intakes in those with SMI compared with the general
population(17–19) and lower consumption of nutrient-dense foods
such as vegetables, dairy products and legumes(20).
Higher energy intake contributes to weight gain and diabetes
and CVD risk(21); this is compounded by high levels of seden-
tariness and lower BMR in people with SMI(22,23). Given the
dietary behaviours described above, interventions to reduce
energy intake and improve diet quality, by increasing core foods
such as fruits, vegetables, whole-grains, lean meats and dairy
foods and by reducing discretionary foods such as processed
foods high in kilojoules, SFA, added sugars, added salts and/or
alcohol, could be key interventions to improve the physical health
of people with SMI. Further, reducing Na intake is a valid method
of reducing the risk of CVD(24), and lowering the glycaemic load
may reduce the risk of type 2 diabetes and CVD(25,26).
Despite evidence that lifestyle intervention improves the
physical and biochemical measures in both early psy-
chosis(27,28) and enduring SMI(29–31), few studies have evaluated
the impact of lifestyle interventions on nutritional intake. To
date, no studies have assessed the impact of preventative
nutrition interventions delivered to youth with first-episode
psychosis (FEP) and the feasibility and acceptability of such
interventions in this vulnerable population.
The aims of this study were as follows: (i) to report the
dietary intake of youth with a FEP, (ii) to evaluate the feasibility
and acceptability of a 12-week intensive dietitian-delivered
nutrition intervention soon after initiation of APM and (iii) to




Dietetic consultations were one component of the multi-
disciplinary Keeping the Body in Mind (KBIM) lifestyle and life
skills intervention that was evaluated in a cluster-controlled
study described elsewhere(28). The intervention included an
exercise physiologist-led physical activity programme and
behavioural support, along with the dietetic intervention
described below. All clients from one clinical service (Bondi
Early Psychosis Program (EPP)) were offered the KBIM
package of care. The comparison site (Liverpool Early
Psychosis Intervention Program (EPIP)) received treatment
as usual involving best-practice early intervention for FEP,
without the KBIM lifestyle and life skills intervention. The
study received ethics approval from the South Eastern
Sydney Local Health District Human Research Ethics Committee
(ref no: 13/040; LNR/13/POWH/85).
Participants/setting
All clients referred to the Bondi EPP, an early intervention
service within a community healthcare centre, over a 12-month
period, between February 2013 and February 2014, were invi-
ted to participate in the on-site nutrition intervention as part of
the KBIM programme. The EPP clinical programme includes a
multidisciplinary team focused on the recovery of normal life
trajectory, using second-generation APM, other psychotropic
medications as indicated (e.g. mood stabilisers and anti-
depressants), combined with community-based case-manage-
ment and targeted behaviour and group programmes. Clients
referred to the Liverpool EPIP served as a control group for the
broader lifestyle intervention study; however, baseline and
post-intervention nutritional intakes were not assessed at this
site. Referral pathways for both EPP and EPIP included (i) acute
inpatient units, (ii) general practitioner referral or (iii) transfer
from another health service. Inclusion criteria were as follows:
(i) first-episode psychosis, (ii) aged 15–25 years old and (iii) less
than 1 month since commencement of APM. All participants
met criteria for FEP before commencing APM. Those with more
than 1 month of treatment with APM were excluded, as such
treatment may already have resulted in significant weight gain
and/or cardiometabolic disturbances. No eligible participants
were prescribed medications to treat cardiometabolic compli-
cations including hypercholesterolaemia, type 2 diabetes and
hypertension at commencement of the study. Psychiatric diag-
noses were confirmed by treating psychiatrists during the
course of treatment according to Diagnostic and Statistical
Manual of Mental Disorder (DSM-5) criteria(32).
Intervention
The dietitian offered weekly structured individual dietetic con-
sultations for 12 weeks and focused on specific educational
modules, utilising motivational interviewing and SMART (Spe-
cific, Measurable, Achievable, Relevant, Time Specific) goals(33).
A full assessment including medical and physical health history,
together with a comprehensive diet history, was completed at
the initial appointment. Subsequent consultations ranged from
30 to 60min in duration and included a 24-h recall, diet history
or food diary review plus education module(s) and goal setting.
Educational modules delivered to all participants within the
individual dietetic consultations targeted weight management,
core foods and nutritional adequacy, and recommended serves
as per the Australian Dietary Guidelines(34). Additional topics
included meal structure, portion sizes, mindful eating, healthier
eating and takeaway choices, label reading and budgeting.
These subsequent topics were prioritised by the dietitian based
on individual needs.
The dietitian facilitated a weekly group shopping tour and
cooking session with assistance from a mental health nurse
specialist. The dietitian and group members walked to the local
supermarket to purchase ingredients, and then returned to the
community centre to prepare lunch. During the weekly
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shopping tour and cooking session, education was provided
and reinforced regarding nutritional requirements, healthy food
choices, fresh food selection, food energy density, salt content,
food safety as well as a variety of cooking skills. Both compo-
nents of the nutrition intervention were offered weekly as part
of standard care for people attending the Bondi EPP.
Participants also had the opportunity to take part in a weekly
sports group and had access to an on-site gym supervised by an
exercise physiologist.
Outcome measures
Energy intake, macronutrient and micronutrient intakes and
glycaemic load were derived from a validated semi-quantita-
tive/FFQ, the Dietary Questionnaire for Epidemiological Studies
(DQES), developed by the Cancer Council of Victoria
(Australia)(35). Following an explanation from the dietitian,
participants self-completed the DQES based on intake over the
last 3 months. Further assistance from the dietitian was provided
if requested. Completed DQES forms were returned to the
Cancer Council of Victoria for analysis, providing data on out-
comes listed above. Feasibility and acceptability of the dietary
consultations and group sessions were evaluated by a con-
sumer survey (described elsewhere(36)), through examination
of attrition during the course of the intervention and through the
number of consultations and weekly group sessions attended.
The Australian Recommended Food Score (ARFS) was used to
determine the proximity of core foods intake compared with
the Australian Dietary Guidelines(34). The ARFS is a validated
tool for use in the Australian population, producing an overall
score, out of a possible 74 points, with reference to core
food groups(37,38). Discretionary food intake was measured
separately by daily intake (g).
Statistical analysis methods
Baseline evaluation compared general dietary patterns including
energy, fibre, Na, alcohol and discretionary food intakes with
estimated energy requirements and national standards for
recommended intakes(39). BMR and estimated energy require-
ments were calculated using the Schofield equation(40). Energy
under-reporting was classified as an energy intake (EI):BMR
ratio<1·2. The pre-post evaluation assessed change in a range of
nutritional factors that can impact on cardiometabolic health,
including core food groups, discretionary foods, energy intake
(kJ), Na intake (mg) and glycaemic load. Outcome measures
were assessed using paired-sample t tests. Non-parametric
χ2 analysis was used for categorical variables. Partial η2 (ηp
2)
effect sizes were calculated for mean change scores. Partial η2
(ηp
2) effect sizes were considered small at 0·10, medium at 0·25
and large at 0·40. Pearson’s correlations were calculated between
mean change scores and mean number of contacts with
clinicians. Repeated-measures ANOVA were calculated for mean
change scores in anthropometric measures. Analyses were
conducted using SPSS, version 22 package. A Bonferroni’s
correction was applied to mean change scores assessed before
and after intervention.
Results
During the recruitment period, twenty-seven participants
completed baseline measures for the 12-week programme
(twelve females and fifteen males, mean age= 20·5 (SD 2·4)
years). Clients were predominantly Caucasian (n 14, 52%), and
in decreasing frequency Asian (n 5, 19%), Middle Eastern (n 3,
11%), Indigenous Australians (n 2, 7%), Maori/Pacific Islanders
(n 2, 7%) and African-Americans (n 1, 4%). Diagnoses were as
follows: schizophreniform disorder (n 12, 45%), bipolar affective
disorder (n 8, 30%) schizoaffective disorder (n 2, 7%), schizo-
phrenia (n 2, 7%), major depression with psychotic features
(n 2, 7%) and brief psychotic disorder (n 1, 4%). A range of
mood-stabiliser, antipsychotic and antidepressant medications
was prescribed. In total, 50% of the sample had unchanged
medication for the duration of the intervention. Some changes in
antipsychotic dosage occurred for the remaining participants
(28% decreased, 17% increased). For one patient, APM was
switched during the course of the intervention. Demographic,
diagnostic and medication data are provided in Table 1.
Table 1. Characteristics of clients referred to the Bondi Early Psychosis
Program and those who completed the intervention










Mean 20·5 20·0 t(25)=1·53 0·50
SD 2·4 2·3
Female 12 44 9 50 χ2=0·68 0·68
Ethnicity
Caucasian 14 52 9 50
Indigenous
Australians
2 7 1 6
Asian 5 19 4 22 χ2=4·44 0·49
African-American 1 4 0 0
Maori/Pacific Islander 2 7 1 6
Middle Eastern 3 11 3 16
DSM-IV diagnoses
Brief psychotic disorder 1 4 0 0
Schizophreniform 12 45 9 50
Schizophrenia 2 7 1 6 χ2=7·88 0·16
Schizoaffective disorder 2 7 0 0
Bipolar affective disorder 8 30 6 33
Major depression with
psychosis
2 7 2 11
Psychotropic medications
Mood-stabiliser
Lithium 4 15 3 17 χ2=0·15 0·59
Sodium valproate 2 7 1 6 χ2=0·27 1·00
Antipsychotic
Risperidone 6 22 5 28 χ2=0·96 0·63
Quetiapine 9 33 5 28 χ2=0·32 0·68
Olanzapine 5 19 4 21 χ2=0·96 0·63
Aripipirozole 4 15 1 6 χ2=3·67 0·09
Paliperidone 2 7 2 11 χ2=1·08 0·54
Venlafaxine 2 7 0 0 χ2=0·27 1·00
Antipsychotic
polypharmacy
2 7 1 6 χ2=0·27 1·00
Antidepressant
Citalopram 2 7 2 11 χ2=1·08 0·54
Escitalopram 2 7 2 11 χ2=1·08 0·54
Sertraline 1 4 0 0 χ2=2·07 0·33
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At baseline, there was no difference between groups in mean
weight (KBIM= 67·6 (SD 13·2) kg, control= 75·8 (SD 18·8) kg),
BMI (KBIM= 23·2 (SD 3·1) kg/m2, control= 24·8 (SD 3·3) kg/m2)
or waist circumference (KBIM= 83·4 (SD 10·5) cm, control= 83·0
(SD 9·1) cm) (all P-values>0·39). The multidisciplinary KBIM
lifestyle and life skills intervention restricted antipsychotic-
induced weight gain to a mean 1·1 kg (95% CI −0·3, 2·5) during
the 12-week intervention, whereas the control group had a
mean weight gain of 7·8 kg (95% CI 4·8, 10·7), F1,28= 24·4
(P< 0·001). There was no change in waist circumference in the
KBIM group, −0·3 (95% CI −2·3, 1·6) cm, whereas the control
group gained a mean 7·1 cm (95% CI 4·8, 9·4), F1,28= 27·1
(P< 0·001).
All participants completed the DQES at baseline. Baseline
energy, discretionary food, Na, glycaemic load and diet quality
intakes are described in Table 2. The mean reported energy
intake was not significantly different from the estimated energy
requirement (t(26)= − 0·4, P= 0·67). Energy was under-
reported in 41% (n 11, EI:BMR range 0·63–1·10). After
accounting for under-reporting, reported energy intake, 11 385
(SD 3601) kJ, was significantly higher than the estimated energy
requirement, 9550 (SD 1574) kJ, 1833 (SD 3067) kJ, t(15)= 2·39,
P= 0·03.
Two-thirds of the participants (nine females and nine males,
mean age= 20·0 (SD 2·1) years; range 17–24 years) remained
engaged at the completion of the 12-week nutrition interven-
tion. Reasons for disengagement included the following: five
were unable to be contacted, three discontinued treatment with
the mental healthcare service, one was re-admitted to inpatient
care during intervention and one was incarcerated during the
intervention period. There were no significant differences in
age (P= 0·5), sex (P= 0·7), ethnicity (P= 0·5) or diagnoses
(P= 0·2) between those who remained engaged in the pro-
gramme and those who disengaged. There was no difference in
rates of mood-stabiliser, antidepressant, antipsychotic pre-
scription or antipsychotic polypharmacy between those who
remained engaged in the programme and those who disen-
gaged (P≥ 0·09).
The mean number of contacts with the dietitian was
8·2 (median= 7·5, range 5–12) (individual consultations= 6·1
(median= 6·5, range 2–12) and shopping/cooking group= 2·1
(median= 2, range 0–5)). The mean number of contacts with
the exercise physiologist was 10·9 (median= 11, range 0–25).
There was a trend to significance between the number of
contacts with the dietitian and the number of contacts with the
exercise physiologist (r 0·46, P= 0·05).
At completion of the 12-week programme, significant quan-
titative and qualitative changes were evident. Daily energy
intake was reduced by 1956 kJ (95% CI −2897, −1020, ηp
2 = 0·51,
P< 0·001). This was reflected in reductions in carbohydrate
(−54 g/d, P< 0·001), sugar (−15 g/d, P= 0·08), protein (−13 g/d,
P= 0·04) and fat (−22 g/d, P= 0·001) intakes. Fibre intake was
not significantly different before and after evaluations. Energy
was under-reported in 50% of the participants who remained
engaged at the 12-week point (n 9; EI:BMR range 0·82–1·10).
There was no relationship between energy underestimation at
baseline and change in weight over the 12-week intervention
(R 0·23, P= 0·37) (Table 3).
After the 12-week programme, discretionary food intake
reduced by 47% (−94·0 g, 95% CI −138·9, −48·3 g, ηp
2 = 0·53,
Table 2. Baseline nutritional intake for twenty-seven participants (all participants), compared with sixteen participants (accounting for under-reporting), and
recommended intakes
Baseline results Baseline results (accounting for under-reporting)
Male (n 15) Female (n 12) Male (n 9) Female (n 7)
Estimated energy requirement
recommended daily intake(41)
Unit of measure n % n % n % n % Male Female
Energy kJ 11 102 7260 13 624 8503 10 989 8202
Discretionary foods kJ 4218 38 2613 36 4866 36 3107 37 Limit Limit
Fibre g 25 19 26·1 23·0 30 25
Na mg 3162 2253 4322 2598 2300UL 2300UL
Alcohol g 10 8 20 20
UL, Upper limit.
Table 3. Mean change of eighteen participants from baseline to after the 12-week intervention
(Mean values, standard deviations and 95% confidence intervals)
Mean at baseline SD Mean at 12 weeks SD Mean change 95% CI Paired-sample t test Effect size
Energy (kJ/d) 8263 2205 6306 1858 − 1958 − 2900, −1021
Energy (kcal/d) 1975 527 1507 444 − 468 − 693, −244 t(17)=4·4, P<0·001* ηp2=0·51
Discretionary foods (g) 200·3 77·6 106·3 69·5 −94·0 − 139·8, −48·3 t(17)=4·3, P<0·001* ηp2=0·53
Na (mg) 2708 791 1995 648 − 713 − 1063, −364 t(17)=4·3, P<0·001* ηp2=0·52
Glycaemic load 113·5 37·1 80·0 25·7 −33·5 − 47·5, −19·5 t(17)=5·0, P<0·001* ηp2=0·60
Diet quality score (ARFS) 28·1 11·4 31·6 11·8 3·6 0·2, 6·9 t(17)= 2·3, P=0·038 ηp
2=0·23
ARFS, Australian Recommended Food Score.
* Statistically significant after applying Bonferroni’s correction.
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P< 0·001), with associated reductions in Na intake, −713mg
(95% CI −1063, −364, ηp
2 = 0·52, P< 0·001), and glycaemic load,
−33·5 (95% CI −47·5, −19·5, ηp
2 = 0·60, P< 0·001). Reductions in
discretionary food intake correlated with reductions in overall
energy intake (r 0·57, P= 0·01). There was an increase in overall
diet quality score (3·6 (95% CI 0·3, 6·8, ηp
2 = 0·23, P= 0·03)), not
statistically significant after applying Bonferroni’s correction for
multiple comparisons.
To further examine the components of diet quality, an
analysis of diet quality subgroups was performed, with results
shown in Table 4. The trend in improved diet quality score was
driven by increased vegetable variety and frequency (2·4 (95%
CI 0·3, 1·0, P= 0·031)).
The correlation between greater contact with the dietitian and
lower energy intake approached significance (r 0·45, P= 0·06),
and there was also a trend for the relationship between lower
Na intake and number of contacts with the exercise physiologist
(r 0·46, P= 0·05). The magnitude of change in weight, waist
circumference, discretionary food, glycaemic load and diet
quality was not significantly correlated with contact with either
the dietitian or the exercise physiologist (all r-values<0·45, all
P-values>0·06).
Discussion
The present study demonstrated that (i) the dietary intake in
youth early in their first episode of psychosis appears to be
higher than required, driving the rapid weight gain seen with
the commencement of APM, (ii) a 12-week dietary intervention
was feasible and accepted by the majority of clients and (iii) the
intervention was effective in improving dietary intake.
At baseline, reported energy intake did not differ significantly
from estimated energy requirement. However, once accounted
for under-reporting, reported energy intake was significantly
higher than estimated energy, coinciding with frequent
reporting of increased hunger in those commencing
antipsychotic treatment, leading to rapid weight gain, similar to
that seen in the control group. Future studies utilising weighed
food records in the early stages of FEP treatment are required to
confirm these findings.
A mean contact with the dietitian of 8·2, range 5–12, suggests
that participants accepted the intervention. The individual
consultations had a higher attendance rate compared with the
cooking group. The low attendance rate in the cooking group
may be explained in part by the session being offered at a set
time each week, in contrast to the individual consultations,
which were tailored to the participants’ availability.
The results of the intensive 12-week intervention suggest that
overall intake of food in this target group can be improved, with
poor-quality, energy-dense, discretionary foods replaced by
core foods such as vegetables. The reduction in energy intake
provides a means to attenuate antipsychotic-induced weight
gain. Indeed, the multifaceted KBIM program demonstrated that
weight gain could be prevented in the majority of youth com-
mencing APM(28).
The 12-week intervention also resulted in a reduction in Na
intake, a proven risk factor for hypertension and heart disease.
Na intake was reduced to within the Australian recommended
upper limit of intake (<2300mg/d)(24).
Although intake of discretionary foods, which are char-
acterised by high-sugar, high-fat, non-nutritious foods,
decreased significantly, it was not possible to assess the change
in added sugar consumption. Future studies should assess the
impact of lifestyle intervention on added sugar with recent
studies suggesting a link to CVD(41) and recent changes in
World Health Organization(42) recommendations.
A recent study in enduring mental illness demonstrated that a
telephone-delivered nutrition intervention reduced inactivity
and improved fruit and vegetable intake, as well as overall diet
quality in those with established illness(43). Importantly, the
study also found significant increases in quality of life and
global functioning. Although there were increases in participant
vegetable intake in our study, fruit intake remained relatively
unchanged. This may have been due to participants already
meeting the recommendations of 2 servings of fruit/d at base-
line assessment. In addition to monetary reimbursement and
free fruit and vegetables boxes provided in Baker et al.’s(43)
study, inclusion criteria specified only those consuming <7 fruit
and vegetable serves/d. This may account, in part, for the large
effect sizes seen in the study. Future studies assessing the cost-
benefits of differing delivery methods would assist the design
and delivery of nutrition interventions into standard practice.
At present, there are no recommended ranges for diet quality
score when using the Australian Recommended Food Score.
Mean diet quality scores in FEP clients were found to be lower
than mean scores in established illness(43) and in Australian
adult women of the general population(44).
This study has a number of limitations, most notably the lack
of age-, sex- and socio-demographic characteristic-matched
controls. This was due to the pragmatic nature of this study,
which aimed to evaluate the effectiveness of a real-world
Table 4. Mean change in diet quality score (Australian Recommended Food Score) by subgroup
(Mean values, standard deviations and 95% confidence intervals)
Maximum score Mean at baseline SD Mean at 12 weeks SD Mean change 95% CI Paired-sample t test
Vegetable 22 8·44 5·40 10·94 6·15 2·50 0·26, 4·74 t(17)= 2·36, P=0·03
Fruit 14 5·44 3·33 5·33 3·31 − 0·11 −1·36, 1·14 t(17)= 0·19, P=0·85
Grain 14 4·89 1·38 5·17 1·25 0·28 −0·52, 1·07 t(17)= 0·74, P=0·47
Protein 14 5·28 3·03 5·72 2·22 0·44 −0·54, 1·43 t(17)= 0·95, P=0·35
Dairy products 7 2·28 1·07 2·50 1·15 0·22 −0·25, 0·69 t(17)= 1·00, P=0·33
Fat 1 0·50 0·51 0·39 0·50 − 0·11 −0·35, 0·12 t(17)= 1·00, P=0·33
Alcohol 2 1·22 0·73 1·56 0·62 0·33 −0·01, 0·67 t(17)= 2·06, P=0·06
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intervention offered to all clients of a service, such that rando-
misation to a comparison condition could not be undertaken.
Although there is considerable evidence of decline in physical
health during in the first 12 weeks of antipsychotic therapy(5,45),
it is likely that nutritional status declines in parallel as weight
gain and metabolic deterioration develop.
Although there was potential for a Hawthorne effect(46), there
were no significant relationships between contact with the
dietitian or exercise physiologist and dietary improvement.
Similar to the majority of nutrition assessment tools, the
responses to the dietary questionnaire were self-reported,
potentially reducing accuracy and increasing risk of bias.
Although the study had a relatively small sample size, the data
showed clear improvements across a number of nutritional
parameters.
In total, 67% successfully completed 12 weeks of intensive
intervention, demonstrating the feasibility and acceptability of
the intervention. Youth with FEP can be difficult to engage, with
30% attrition rates for a range of interventions offered in FEP
services(47), and these drop-out rates are similar to other lifestyle
programmes conducted in people without SMI(48,49).
Clinicians delivering the intervention also noted a number of
potential benefits as a result of the nutrition intervention that
warrant further investigation. Having a nutrition programme
embedded within the EPP was associated with increased
attendance by clients at the community centre, allowing
additional opportunities for client contact by mental health
clinicians. Peer contact within the cooking group may have
contributed to improved social skills and self esteem. Previous
studies(50,51) have demonstrated that improved diet quality
can increase psychosocial function in those with depression.
Correlations between diet quality and psychosocial function
scores in psychotic illness have not been evaluated, and future
studies should assess the relationship between diet quality and
symptomatology.
Conclusion
The integration of dietetic services into community early
psychosis programmes is feasible and acceptable to youth with
FEP with high attendance rates over a short-term period of
12 weeks. If dietary changes are sustained, intensive and early
nutrition intervention may reduce future risk of cardiometabolic
disease in SMI, helping meet the targets identified in the
Healthy Active Lives international declaration for youth with
psychosis (www.iphys.org.au). These targets aim to create a
world where ‘young people experiencing psychosis have the
same life expectancy and expectations of life as their peers who
have not experienced psychosis’. Early intervention in the first
episode of psychosis may have a greater long-term impact on
the health of people with SMI and represents a greater return on
clinician effort than our current practice of late addressing of
poor metabolic health in established chronic mental illness.
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